Drugs List

Drugs A-Z List - K
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drugs List [Browse by brand or generic name]
K-Phos M.F., K-Phos Neutral, K-Phos No. 2, Neutra-Phos, Uro-KP-Neutral potassium phosphate and sodium phosphate (Pronunci - FDA

Description : Each tablet contains 852 mg dibasic sodium phosphate anhydrous, 155 mg monobasic potassium ...

  • Indications
  • K-PHOS® NEUTRAL (potassium and sodium phosphate) increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recomm
  •   Read More
K-Phos M.F., K-Phos Neutral, K-Phos No. 2, Neutra-Phos, Uro-KP-Neutral potassium phosphate and sodium phosphate (Pronunci - Multum

Description : Each tablet contains 852 mg dibasic sodium phosphate anhydrous, 155 mg monobasic potassium ...

  • Indications
  • K-PHOS® NEUTRAL (potassium and sodium phosphate) increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recomm
  •   Read More
K-Phos M.F., K-Phos Neutral, K-Phos No. 2, Neutra-Phos, Uro-KP-Neutral potassium phosphate and sodium phosphate (Pronunci - FDA

Description : Each tablet contains 852 mg dibasic sodium phosphate anhydrous, 155 mg monobasic potassium ...

  • Indications
  • K-PHOS® NEUTRAL (potassium and sodium phosphate) increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recommende
  •   Read More
K-Phos M.F., K-Phos Neutral, K-Phos No. 2, Neutra-Phos, Uro-KP-Neutral  potassium phosphate and sodium phosphate (Pronunc - Multum

Description : Brand Names: K-Phos M.F., K-Phos Neutral, K-Phos No. 2, Neutra-Phos, Uro-KP-Neutral Generic Na...

  • Indications
  • K-PHOS® NEUTRAL (potassium and sodium phosphate) increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recommende
  •   Read More
Kabiven (amino acids, electrolytes, dextrose and lipid) In - FDA

Description : KABIVEN® is a sterile, hypertonic emulsion, for central venous administration, in a Thr...

  • Indications
  • KABIVEN® is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral
  •   Read More
Kabiven (amino acids, electrolytes, dextrose and lipid) In - FDA

Description : KABIVEN® is a sterile, hypertonic emulsion, for central venous administration, in a Thr...

  • Indications
  • KABIVEN® is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral
  •   Read More
Kadcyla (ado-trastuzumab emtansine) for Intravenous Infusi - FDA

Description : KADCYLA (ado-trastuzumab emtansine) is a HER2-targeted antibody-drug conjugate (ADC) which ...

  • Indications
  • KADCYLA®, as a single agent, is indicated for the treatment of patients with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane,
  •   Read More
Kadcyla (ado-trastuzumab emtansine) for Intravenous Infusi - FDA

Description : KADCYLA (ado-trastuzumab emtansine) is a HER2-targeted antibody-drug conjugate (ADC) which ...

  • Indications
  • KADCYLA®, as a single agent, is indicated for the treatment of patients with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane,
  •   Read More
Kalbitor ecallantide (Pronunciation: e KAL an tide) - FDA

Description : KALBITOR (ecallantide) is a human plasma kallikrein inhibitor for injection for subcutaneou...

  • Indications
  • KALBITOR® (ecallantide) is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older.
  •   Read More
Kalbitor ecallantide (Pronunciation: e KAL an tide) - Multum

Description : KALBITOR (ecallantide) is a human plasma kallikrein inhibitor for injection for subcutaneou...

  • Indications
  • KALBITOR® (ecallantide) is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older.
  •   Read More
Kalbitor ecallantide (Pronunciation: e KAL an tide) - FDA

Description : KALBITOR (ecallantide) is a human plasma kallikrein inhibitor for injection for subcutaneou...

  • Indications
  • KALBITOR® (ecallantide) is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older.
  •   Read More
Kalbitor ecallantide (Pronunciation: e KAL an tide) - Multum

Description : KALBITOR (ecallantide) is a human plasma kallikrein inhibitor for injection for subcutaneou...

  • Indications
  • KALBITOR® (ecallantide) is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older.
  •   Read More
Kaletra lopinavir and ritonavir (Pronunciation: loe PIN a - FDA

Description : KALETRA (lopinavir/ritonavir) is a co-formulation of lopinavir and ritonavir. Lopinavir is ...

  • Indications
  • KALETRA is indicated in combination with other antiretroviral agents for the treatment of HIV1 infection in adults and pediatric patients (14 days and older). The followi
  •   Read More
Kaletra  lopinavir and ritonavir (Pronunciation: loe PIN a - Multum

Description : KALETRA (lopinavir/ritonavir) is a co-formulation of lopinavir and ritonavir. Lopinavir is ...

  • Indications
  • KALETRA is indicated in combination with other antiretroviral agents for the treatment of HIV1 infection in adults and pediatric patients (14 days and older). The followi
  •   Read More
Kaletra lopinavir and ritonavir (Pronunciation: loe PIN a - FDA

Description : KALETRA (lopinavir/ritonavir) is a co-formulation of lopinavir and ritonavir. Lopinavir is ...

  • Indications
  • KALETRA is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients (14 days and older). The fol
  •   Read More
Kaletra lopinavir and ritonavir (Pronunciation: loe PIN a - Multum

Description : KALETRA (lopinavir/ritonavir) is a co-formulation of lopinavir and ritonavir. Lopinavir is ...

  • Indications
  • KALETRA is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients (14 days and older). The fol
  •   Read More
Kaletra lopinavir and ritonavir (Pronunciation: loe PIN a - FDA

Description : KALETRA (lopinavir/ritonavir) is a co-formulation of lopinavir and ritonavir. Lopinavir is ...

  • Indications
  • KALETRA is indicated in combination with other antiretroviral agents for the treatment of HIV1 infection in adults and pediatric patients (14 days and older). The followi
  •   Read More
Kaletra lopinavir and ritonavir (Pronunciation: loe PIN a - Multum

Description : KALETRA (lopinavir/ritonavir) is a co-formulation of lopinavir and ritonavir. Lopinavir is ...

  • Indications
  • KALETRA is indicated in combination with other antiretroviral agents for the treatment of HIV1 infection in adults and pediatric patients (14 days and older). The followi
  •   Read More
Kaletra lopinavir and ritonavir (Pronunciation: loe PIN a - FDA

Description : KALETRA is a co-formulation of lopinavir and ritonavir. Lopinavir is an inhibitor of the HI...

  • Indications
  • KALETRA is indicated in combination with other antiretroviral agents for the treatment of HIV1 infection in adults and pediatric patients (14 days and older). The followi
  •   Read More
Kaletra lopinavir and ritonavir (Pronunciation: loe PIN a - Multum

Description : KALETRA is a co-formulation of lopinavir and ritonavir. Lopinavir is an inhibitor of the HI...

  • Indications
  • KALETRA is indicated in combination with other antiretroviral agents for the treatment of HIV1 infection in adults and pediatric patients (14 days and older). The followi
  •   Read More
Kalexate, Kayexalate, Kionex sodium polystyrene sulfonate (Pronunciation: SOE d - FDA

Description : Kayexalate, brand of sodium polystyrene sulfonate is a benzene, diethenyl-polymer, with eth...

  • Indications
  • Kayexalate (sodium polystyrene) is indicated for the treatment of hyperkalemia.
  •   Read More
Kalexate, Kayexalate, Kionex sodium polystyrene sulfonate (Pronunciation: SOE d - FDA

Description : Kayexalate, brand of sodium polystyrene sulfonate is a benzene, diethenyl-polymer, with eth...

  • Indications
  • Kayexalate (sodium polystyrene) is indicated for the treatment of hyperkalemia.
  •   Read More
Kalexate, Kayexalate, Kionex sodium polystyrene sulfonate (Pronunciation: SOE d - FDA

Description : Kionex® brand of sodium polystyrene sulfonate is a benzene, diethenyl- polymer with eth...

  • Indications
  • Kionex® (sodium polystyrene sulfonate) is indicated for the treatment of hyperkalemia.
  •   Read More
Kalexate, Kayexalate, Kionex sodium polystyrene sulfonate (Pronunciation: SOE d - Multum

Description : Kionex® brand of sodium polystyrene sulfonate is a benzene, diethenyl- polymer with eth...

  • Indications
  • Kionex® (sodium polystyrene sulfonate) is indicated for the treatment of hyperkalemia.
  •   Read More
Kalexate, Kayexalate, Kionex sodium polystyrene sulfonate (Pronunciation: SOE d - FDA

Description : Kayexalate, brand of sodium polystyrene sulfonate is a benzene, diethenyl-polymer, with ethenyl...

  • Indications
  • Kayexalate (sodium polystyrene) is indicated for the treatment of hyperkalemia.
  •   Read More
Kalexate, Kayexalate, Kionex sodium polystyrene sulfonate (Pronunciation: SOE d - Multum

Description : Kayexalate, brand of sodium polystyrene sulfonate is a benzene, diethenyl-polymer, with ethenyl...

  • Indications
  • Kayexalate (sodium polystyrene) is indicated for the treatment of hyperkalemia.
  •   Read More
Kalexate, Kayexalate, Kionex sodium polystyrene sulfonate (Pronunciation: SOE d - Multum

Description : Kionex® brand of sodium polystyrene sulfonate is a benzene, diethenyl- polymer with ethenyl...

  • Indications
  • Kionex® (sodium polystyrene sulfonate) is indicated for the treatment of hyperkalemia.
  •   Read More
Kalydeco ivacaftor (Pronunciation: EYE va KAF tor) - FDA

Description : The active ingredient in KALYDECO tablets is ivacaftor, which has the following chemical na...

  • Indications
  • KALYDECO is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated for the treatment of cystic fibrosis (CF) in patients age 6 years and older
  •   Read More
Kalydeco ivacaftor (Pronunciation: EYE va KAF tor) - Multum

Description : The active ingredient in KALYDECO tablets is ivacaftor, which has the following chemical na...

  • Indications
  • KALYDECO is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated for the treatment of cystic fibrosis (CF) in patients age 6 years and older
  •   Read More
Kalydeco ivacaftor (Pronunciation: EYE va KAF tor) - Multum

Description : The active ingredient in KALYDECO tablets is ivacaftor, which has the following chemical na...

  • Indications
  • KALYDECO is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated for the treatment of cystic fibrosis (CF) in patients age 6 years and older
  •   Read More
Kantrex kanamycin (Pronunciation: KAN a MYE sin) - FDA

Description : Kanamycin sulfate is an aminoglycoside antibiotic produced by Streptomyces kanamyceticus. I...

  • Indications
  • Kanamycin is indicated in the short term treatment of serious infections caused by susceptible strains of the designated microorganisms below. Bacteriological studies to i
  •   Read More
Kantrex kanamycin (Pronunciation: KAN a MYE sin) - Multum

Description : Kanamycin sulfate is an aminoglycoside antibiotic produced by Streptomyces kanamyceticus. I...

  • Indications
  • Kanamycin is indicated in the short term treatment of serious infections caused by susceptible strains of the designated microorganisms below. Bacteriological studies to i
  •   Read More
Kantrex kanamycin (Pronunciation: KAN a MYE sin) - FDA

Description : Kanamycin sulfate is an aminoglycoside antibiotic produced by Streptomyces kanamyceticus. I...

  • Indications
  • Kanamycin is indicated in the short term treatment of serious infections caused by susceptible strains of the designated microorganisms below. Bacteriological studies to i
  •   Read More
Kantrex kanamycin (Pronunciation: KAN a MYE sin) - Multum

Description : Kanamycin sulfate is an aminoglycoside antibiotic produced by Streptomyces kanamyceticus. I...

  • Indications
  • Kanamycin is indicated in the short term treatment of serious infections caused by susceptible strains of the designated microorganisms below. Bacteriological studies to i
  •   Read More
Kapidex Delayed Release Capsules dexlansoprazole) Delayed Release Capsules - FDA

Description : The active ingredient in KAPIDEX (dexlansoprazole delayed release capsules) (dexlansoprazol...

  • Indications
  • Healing of Erosive Esophagitis KAPIDEX (dexlansoprazole delayed release capsules) is indicated for healing of all grades of erosive esophagitis (EE) for up to 8 weeks. M
  •   Read More
Kapvay (clonidine hydrochloride) Extended-Release Tablets - FDA

Description : KAPVAY (clonidine hydrochloride) extended-release is a centrally acting alpha2-adrenergic a...

  • Indications
  • KAPVAY™ (clonidine hydrochloride) extended-release is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive
  •   Read More
Kapvay (clonidine hydrochloride) Extended-Release Tablets - FDA

Description : KAPVAY (clonidine hydrochloride) extended-release is a centrally acting alpha2-adrenergic a...

  • Indications
  • KAPVAY™ (clonidine hydrochloride) extended-release is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive
  •   Read More
Karbinal ER (carbinoxamine maleate) Extended-Release Oral Susp - FDA

Description : Each 5 mL of Karbinal ER Extended-release Oral Suspension contains carbinoxamine complexed ...

  • Indications
  • Karbinal ER Extended-release Oral Suspension is an H1 receptor antagonist indicated for the symptomatic treatment of: Seasonal and perennial allergic rhinitis Vasomot
  •   Read More
Karbinal ER (carbinoxamine maleate) Extended-Release Oral Susp - FDA

Description : Each 5 mL of Karbinal ER Extended-release Oral Suspension contains carbinoxamine complexed ...

  • Indications
  • Karbinal ER Extended-release Oral Suspension is an H1 receptor antagonist indicated for the symptomatic treatment of: Seasonal and perennial allergic rhinitis Vasomot
  •   Read More
Kazano alogliptin and metformin (Pronunciation: AL oh GLI - FDA

Description : KAZANO tablets contain 2 oral antihyperglycemic drugs used in the management of type 2 diab...

  • Indications
  • Monotherapy and Combination Therapy KAZANO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple
  •   Read More
Kazano alogliptin and metformin (Pronunciation: AL oh GLI - Multum

Description : KAZANO tablets contain 2 oral antihyperglycemic drugs used in the management of type 2 diab...

  • Indications
  • Monotherapy and Combination Therapy KAZANO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple
  •   Read More
Kazano alogliptin and metformin (Pronunciation: AL oh GLI - FDA

Description : KAZANO tablets contain 2 oral antihyperglycemic drugs used in the management of type 2 diab...

  • Indications
  • Monotherapy and Combination Therapy KAZANO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple
  •   Read More
Kazano alogliptin and metformin (Pronunciation: AL oh GLI - Multum

Description : KAZANO tablets contain 2 oral antihyperglycemic drugs used in the management of type 2 diab...

  • Indications
  • Monotherapy and Combination Therapy KAZANO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple
  •   Read More
Kcentra Prothrombin Complex Concentrate (Human) - FDA

Description : Kcentra is a purified, heat-treated, nanofiltered and lyophilized non-activated four-factor...

  • Indications
  • Kcentra, (Prothrombin Complex Concentrate (Human)), is indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.
  •   Read More
Kcentra Prothrombin Complex Concentrate (Human - FDA

Description : Kcentra is a purified, heat-treated, nanofiltered and lyophilized non-activated four-factor...

  • Indications
  • Kcentra, (Prothrombin Complex Concentrate (Human)), is indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.
  •   Read More
KCL in D5NS (potassium chloride in 5% dextrose and sodium chlo - FDA

Description : Potassium Chloride in 5% Dextrose and Sodium Chloride (potassium chloride in 5% dextrose an...

  • Indications
  • Potassium Chloride in 5% Dextrose and Sodium Chloride Injection, USP is indicated as a source of water, electrolytes and calories.
  •   Read More
KCL in D5NS Potassium Chloride in 5% Dextrose and Sodium Chlor - FDA

Description : Potassium Chloride in 5% Dextrose and Sodium Chloride (potassium chloride in 5% dextrose an...

  • Indications
  • Potassium Chloride in 5% Dextrose and Sodium Chloride Injection, USP is indicated as a source of water, electrolytes and calories.
  •   Read More
KCL in D5W (potassium chloride in 5% dextrose injection) - FDA

Description : (See chart below for quantitative information.) Potassium Chloride in 5% Dextrose Injectio...

  • Indications
  • These intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes, calories, and water for hydration.
  •   Read More
KCL in D5W Potassium Chloride in 5% Dextrose Injections USP ( - FDA

Description : (See chart below for quantitative information.) Potassium Chloride in 5% Dextrose Injectio...

  • Indications
  • These intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes, calories, and water for hydration.
  •   Read More
KCL in NS (potassium chloride in sodium chloride injection) - FDA

Description : Potassium Chloride in Sodium Chloride Injection, USP is a sterile, nonpyrogenic, solution f...

  • Indications
  • Potassium Chloride in Sodium Chloride Injection, USP is indicated as a source of water and electrolytes.
  •   Read More
KCL in NS Potassium Chloride in Sodium Chloride Injection, U - FDA

Description : Potassium Chloride in Sodium Chloride Injection, USP is a sterile, nonpyrogenic, solution f...

  • Indications
  • Potassium Chloride in Sodium Chloride Injection, USP is indicated as a source of water and electrolytes.
  •   Read More
Keflex, Panixine cephalexin (Pronunciation: sef a LEX in) - FDA

Description : Keflex® Capsules (Cephalexin, USP) is a semisynthetic cephalosporin antibiotic intended...

  • Indications
  • Keflex (cephalexin) is indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Respiratory tract infe
  •   Read More
Keflex, Panixine cephalexin (Pronunciation: sef a LEX in) - Multum

Description : Keflex® Capsules (Cephalexin, USP) is a semisynthetic cephalosporin antibiotic intended...

  • Indications
  • Keflex (cephalexin) is indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Respiratory tract infe
  •   Read More
Keflex, Panixine cephalexin (Pronunciation: sef a LEX in) - FDA

Description : Keflex® Capsules (Cephalexin, USP) is a semisynthetic cephalosporin antibiotic intended...

  • Indications
  • Keflex (cephalexin) is indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Respiratory tract infe
  •   Read More
Keflex, Panixine cephalexin (Pronunciation: sef a LEX in) - Multum

Description : Keflex® Capsules (Cephalexin, USP) is a semisynthetic cephalosporin antibiotic intended...

  • Indications
  • Keflex (cephalexin) is indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Respiratory tract infe
  •   Read More
Kelnor, Zovia 1/35, Zovia 1/50 ethinyl estradiol and ethynodiol diacetate (Pronun - FDA

Description : Zovia (ehtynodiol diacetate and ethinyl estradiol tablets) 1/35E-28. Each light pink tablet...

  • Indications
  • Zovia (ehtynodiol diacetate and ethinyl estradiol tablets) 1/35E and Zovia (ehtynodiol diacetate and ethinyl estradiol tablets) 1/50E are indicated for the prevention of pregn
  •   Read More
Kelnor, Zovia 1/35, Zovia 1/50 ethinyl estradiol and ethynodiol diacetate (Pronun - Multum

Description : Zovia (ehtynodiol diacetate and ethinyl estradiol tablets) 1/35E-28. Each light pink tablet...

  • Indications
  • Zovia (ehtynodiol diacetate and ethinyl estradiol tablets) 1/35E and Zovia (ehtynodiol diacetate and ethinyl estradiol tablets) 1/50E are indicated for the prevention of pregn
  •   Read More
Kelnor, Zovia 1/35, Zovia 1/50 ethinyl estradiol and ethynodiol diacetate (Pronun - FDA

Description : Zovia (ehtynodiol diacetate and ethinyl estradiol tablets) 1/35E-28. Each light pink tablet con...

  • Indications
  • Zovia (ehtynodiol diacetate and ethinyl estradiol tablets) 1/35E and Zovia (ehtynodiol diacetate and ethinyl estradiol tablets) 1/50E are indicated for the prevention of pregn
  •   Read More
Kelnor, Zovia 1/35, Zovia 1/50 ethinyl estradiol and ethynodiol diacetate (Pronun - Multum

Description : Zovia (ehtynodiol diacetate and ethinyl estradiol tablets) 1/35E-28. Each light pink tablet con...

  • Indications
  • Zovia (ehtynodiol diacetate and ethinyl estradiol tablets) 1/35E and Zovia (ehtynodiol diacetate and ethinyl estradiol tablets) 1/50E are indicated for the prevention of pregn
  •   Read More
Kemadrin (procyclidine hydrochloride) 5 mg Scored Tablets - FDA

Description : KEMADRIN (procyclidine hydrochloride) is a synthetic antispasmodic compound of relatively l...

  • Indications
  • KEMADRIN (procyclidine hydrochloride) is indicated in the treatment of parkinsonism including the postencephalitic, arteriosclerotic, and idiopathic types. Partial contro
  •   Read More
Kemadrin (procyclidine hydrochloride) 5 mg Scored Tablets - FDA

Description : KEMADRIN (procyclidine hydrochloride) is a synthetic antispasmodic compound of relatively l...

  • Indications
  • KEMADRIN (procyclidine hydrochloride) is indicated in the treatment of parkinsonism including the postencephalitic, arteriosclerotic, and idiopathic types. Partial contro
  •   Read More
KEMSTRO (baclofen) Orally Disintegrating Tablets - FDA

Description : KEMSTRO™ (baclofen orally disintegrating tablets) is a muscle relaxant and antispasti...

  • Indications
  • KEMSTRO™ (baclofen) is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms
  •   Read More
Kemstro (baclofen) Orally Disintegrating Tablets - FDA

Description : KEMSTRO™ (baclofen orally disintegrating tablets) is a muscle relaxant and antispasti...

  • Indications
  • KEMSTRO™ (baclofen) is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms
  •   Read More
Kenalog Spray (triamcinolone acetonide) Topical Aerosol, USP (0. - FDA

Description : The topical corticosteroids constitute a class of primarily synthetic steroids used as anti...

  • Indications
  • Kenalog Spray (Triamcinolone Acetonide Topical Aerosol, USP) is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
  •   Read More
Kepivance palifermin (Pronunciation: PAL ee FER min) - FDA

Description : Kepivance (palifermin) is a truncated human KGF produced by recombinant DNA technology in E...

  • Indications
  • Indications Kepivance is a mucocutaneous epithelial human growth factor indicated to decrease the incidence and duration of severe oral mucositis in patients with hemato
  •   Read More
Kepivance palifermin (Pronunciation: PAL ee FER min) - Multum

Description : Kepivance (palifermin) is a truncated human KGF produced by recombinant DNA technology in E...

  • Indications
  • Indications Kepivance is a mucocutaneous epithelial human growth factor indicated to decrease the incidence and duration of severe oral mucositis in patients with hemato
  •   Read More
Kepivance palifermin (Pronunciation: PAL ee FER min - FDA

Description : Kepivance (palifermin) is a truncated human KGF produced by recombinant DNA technology in E...

  • Indications
  • Indications Kepivance is a mucocutaneous epithelial human growth factor indicated to decrease the incidence and duration of severe oral mucositis in patients with hemato
  •   Read More
Kepivance palifermin (Pronunciation: PAL ee FER min) - Multum

Description : Kepivance (palifermin) is a truncated human KGF produced by recombinant DNA technology in E...

  • Indications
  • Indications Kepivance is a mucocutaneous epithelial human growth factor indicated to decrease the incidence and duration of severe oral mucositis in patients with hemato
  •   Read More
Keppra Injection (levetiracetam) Injection - FDA

Description : KEPPRA injection is an antiepileptic drug available as a clear, colorless, sterile solution...

  • Indications
  • Partial Onset Seizures KEPPRA is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy.
  •   Read More
Keppra Injection (levetiracetam) Injection - FDA

Description : KEPPRA injection is an antiepileptic drug available as a clear, colorless, sterile solution...

  • Indications
  • Partial Onset Seizures KEPPRA is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy.
  •   Read More
Keppra, Keppra XR levetiracetam (Pronunciation: LEE ve tye RA se tam - FDA

Description : KEPPRA is an antiepileptic drug available as 250 mg (blue), 500 mg (yellow), 750 mg (orange...

  • Indications
  • Partial Onset Seizures KEPPRA is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy.
  •   Read More
Keppra, Keppra XR levetiracetam (Pronunciation: LEE ve tye RA se tam - Multum

Description : KEPPRA is an antiepileptic drug available as 250 mg (blue), 500 mg (yellow), 750 mg (orange...

  • Indications
  • Partial Onset Seizures KEPPRA is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy.
  •   Read More
Keppra, Keppra XR levetiracetam (Pronunciation: LEE ve tye RA se tam - FDA

Description : KEPPRA XR is an antiepileptic drug available as 500 mg and 750 mg (white) extended-release ...

  • Indications
  • KEPPRA XR® is indicated as adjunctive therapy in the treatment of partial onset seizures in patients ≥ 12 years of age with epilepsy.
  •   Read More
Keppra, Keppra XR levetiracetam (Pronunciation: LEE ve tye RA se tam - Multum

Description : KEPPRA XR is an antiepileptic drug available as 500 mg and 750 mg (white) extended-release ...

  • Indications
  • KEPPRA XR® is indicated as adjunctive therapy in the treatment of partial onset seizures in patients ≥ 12 years of age with epilepsy.
  •   Read More
Keppra, Keppra XR levetiracetam (Pronunciation: LEE ve tye RA se tam - FDA

Description : KEPPRA is an antiepileptic drug available as 250 mg (blue), 500 mg (yellow), 750 mg (orange...

  • Indications
  • Partial Onset Seizures KEPPRA is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy.
  •   Read More
Keppra, Keppra XR levetiracetam (Pronunciation: LEE ve tye RA se tam - Multum

Description : KEPPRA is an antiepileptic drug available as 250 mg (blue), 500 mg (yellow), 750 mg (orange...

  • Indications
  • Partial Onset Seizures KEPPRA is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy.
  •   Read More
Keppra, Keppra XR levetiracetam (Pronunciation: LEE ve tye RA se tam - FDA

Description : KEPPRA XR is an antiepileptic drug available as 500 mg and 750 mg (white) extended-release ...

  • Indications
  • KEPPRA XR® is indicated as adjunctive therapy in the treatment of partial onset seizures in patients ≥ 12 years of age with epilepsy.
  •   Read More
Keppra, Keppra XR levetiracetam (Pronunciation: LEE ve tye RA se tam - Multum

Description : KEPPRA XR is an antiepileptic drug available as 500 mg and 750 mg (white) extended-release ...

  • Indications
  • KEPPRA XR® is indicated as adjunctive therapy in the treatment of partial onset seizures in patients ≥ 12 years of age with epilepsy.
  •   Read More
Kerledex (betaxolol hydrochloride and chlorthalidone) - FDA

Description : Kerledex (betaxolol hydrochloride and chlorthalidone) is a combination product indicated fo...

  • Indications
  • Kerledex is indicated in the management of hypertension.
  •   Read More
Kerledex (betaxolol hydrochloride and chlorthalidone) - FDA

Description : Kerledex (betaxolol hydrochloride and chlorthalidone) is a combination product indicated fo...

  • Indications
  • Kerledex is indicated in the management of hypertension.
  •   Read More
Kerlone betaxolol (Pronunciation: bay TAX oh lol) - FDA

Description : Kerlone (betaxolol hydrochloride) is a β1-selective (cardioselective) adrenergic recep...

  • Indications
  • Kerlone (betaxolol hydrochloride) is indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly thiazi
  •   Read More
Kerlone betaxolol (Pronunciation: bay TAX oh lol) - Multum

Description : Kerlone (betaxolol hydrochloride) is a β1-selective (cardioselective) adrenergic recep...

  • Indications
  • Kerlone (betaxolol hydrochloride) is indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly thiazi
  •   Read More
Kerlone betaxolol (Pronunciation: bay TAX oh lol) - FDA

Description : Kerlone (betaxolol hydrochloride) is a β1-selective (cardioselective) adrenergic recep...

  • Indications
  • Kerlone (betaxolol hydrochloride) is indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly thiazi
  •   Read More
Kerlone betaxolol (Pronunciation: bay TAX oh lol) - Multum

Description : Kerlone (betaxolol hydrochloride) is a β1-selective (cardioselective) adrenergic recep...

  • Indications
  • Kerlone (betaxolol hydrochloride) is indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly th
  •   Read More
Kerydin (tavaborole) Topical Solution - FDA

Description : KERYDIN (tavaborole) topical solution, 5% contains tavaborole, 5% (w/w) in a clear, colorle...

  • Indications
  • KERYDIN (tavaborole) topical solution, 5% is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyt
  •   Read More
Kerydin tavaborole) Topical Solution - FDA

Description : KERYDIN (tavaborole) topical solution, 5% contains tavaborole, 5% (w/w) in a clear, colorle...

  • Indications
  • KERYDIN (tavaborole) topical solution, 5% is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton m
  •   Read More
Ketalar ketamine (Pronunciation: KET a meen) - FDA

Description : Ketalar is a nonbarbiturate anesthetic chemically designated dl 2-(0-chlorophenyl)-2-(methy...

  • Indications
  • Ketalar is indicated as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. Ketalar is best suited for short p
  •   Read More
Ketalar ketamine (Pronunciation: KET a meen) - Multum

Description : Ketalar is a nonbarbiturate anesthetic chemically designated dl 2-(0-chlorophenyl)-2-(methy...

  • Indications
  • Ketalar is indicated as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. Ketalar is best suited for short p
  •   Read More
Ketalar ketamine (Pronunciation: KET a meen) - FDA

Description : Ketamine hydrochloride (ketamine hcl) is a nonbarbiturate anesthetic chemically designated ...

  • Indications
  • Ketamine hydrochloride (ketamine hcl) injection is indicated as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxa
  •   Read More
Ketalar ketamine (Pronunciation: KET a meen) - Multum

Description : Ketamine hydrochloride (ketamine hcl) is a nonbarbiturate anesthetic chemically designated ...

  • Indications
  • Ketamine hydrochloride (ketamine hcl) injection is indicated as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxa
  •   Read More
Ketalar ketamine (Pronunciation: KET a meen) - FDA

Description : Ketalar is a nonbarbiturate anesthetic chemically designated dl 2-(0-chlorophenyl)-2-(methy...

  • Indications
  • Ketalar is indicated as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. Ketalar is best suited for short p
  •   Read More
Ketalar ketamine (Pronunciation: KET a meen) - Multum

Description : Ketalar is a nonbarbiturate anesthetic chemically designated dl 2-(0-chlorophenyl)-2-(methy...

  • Indications
  • Ketalar is indicated as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. Ketalar is best suited for short p
  •   Read More
Ketek, Ketek Pak telithromycin (Pronunciation: tel IT roe MYE sin) - FDA

Description : KETEK® tablets contain telithromycin, a semisynthetic antibacterial in the ketolide cla...

  • Indications
  • KETEK (telithromycin) tablets are indicated for the treatment of community-acquired pneumonia (of mild to moderate severity) due to Streptococcus pneumoniae, (including mu
  •   Read More
Ketek, Ketek Pak telithromycin (Pronunciation: tel IT roe MYE sin) - Multum

Description : KETEK® tablets contain telithromycin, a semisynthetic antibacterial in the ketolide cla...

  • Indications
  • KETEK (telithromycin) tablets are indicated for the treatment of community-acquired pneumonia (of mild to moderate severity) due to Streptococcus pneumoniae, (including mu
  •   Read More
Ketek, Ketek Pak telithromycin (Pronunciation: tel IT roe MYE sin) - FDA

Description : KETEK® tablets contain telithromycin, a semisynthetic antibacterial in the ketolide cla...

  • Indications
  • KETEK (telithromycin) tablets are indicated for the treatment of community-acquired pneumonia (of mild to moderate severity) due to Streptococcus pneumoniae, (including mu
  •   Read More
Ketek, Ketek Pak  telithromycin (Pronunciation: tel IT roe MYE sin) - Multum

Description : KETEK® tablets contain telithromycin, a semisynthetic antibacterial in the ketolide cla...

  • Indications
  • KETEK (telithromycin) tablets are indicated for the treatment of community-acquired pneumonia (of mild to moderate severity) due to Streptococcus pneumoniae, (including mu
  •   Read More
Keytruda (pembrolizumab) for Intravenous Infusion - FDA

Description : Pembrolizumab is a humanized monoclonal antibody that blocks the interaction between PD-1 a...

  • Indications
  • KEYTRUDA® (pembrolizumab) is indicated for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRA
  •   Read More
Keytruda  (pembrolizumab) for Intravenous Infusion - FDA

Description : Pembrolizumab is a humanized monoclonal antibody that blocks the interaction between PD-1 a...

  • Indications
  • KEYTRUDA® (pembrolizumab) is indicated for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRA
  •   Read More
Khedezla desvenlafaxine) Extended-release Tablets - FDA

Description : KHEDEZLA Extended-release Tablets for oral administration contains desvenlafaxine, a struct...

  • Indications
  • KHEDEZLA, a serotonin and norepinephrine reuptake inhibitor (SNRI), is indicated for the treatment of major depressive disorder (MDD) [see Clinical Studies and DOSAGE AND ADMI
  •   Read More
Khedezla (desvenlafaxine) Extended-release Tablets - FDA

Description : KHEDEZLA Extended-release Tablets for oral administration contains desvenlafaxine, a struct...

  • Indications
  • KHEDEZLA, a serotonin and norepinephrine reuptake inhibitor (SNRI), is indicated for the treatment of major depressive disorder (MDD) [see Clinical Studies and DOSAGE AND ADMI
  •   Read More
Kineret anakinra (injectable) (Pronunciation: an na KIN ra - FDA

Description : Kineret (anakinra) is a recombinant, nonglycosylated form of the human interleukin-1 recept...

  • Indications
  • Active Rheumatoid Arthritis Kineret is indicated for the reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active
  •   Read More
Kineret anakinra (injectable) (Pronunciation: an na KIN ra - FDA

Description : Kineret (anakinra) is a recombinant, nonglycosylated form of the human interleukin-1 recept...

  • Indications
  • Active Rheumatoid Arthritis Kineret is indicated for the reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active
  •   Read More
Kineret anakinra (injectable) (Pronunciation: an na KIN ra - Multum

Description : Kineret (anakinra) is a recombinant, nonglycosylated form of the human interleukin-1 recept...

  • Indications
  • Active Rheumatoid Arthritis Kineret is indicated for the reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active
  •   Read More
Kinevac sincalide (Pronunciation: SIN ka lide) - FDA

Description : Kinevac (Sincalide for Injection) is a cholecystopancreatic-gastrointestinal hormone peptid...

  • Indications
  • Kinevac (Sincalide for Injection) may be used: (1) to stimulate gallbladder contraction, as may be assessed by contrast agent cholecystography or ultrasonography, or to ob
  •   Read More
Kinevac sincalide (Pronunciation: SIN ka lide) - Multum

Description : Kinevac (Sincalide for Injection) is a cholecystopancreatic-gastrointestinal hormone peptid...

  • Indications
  • Kinevac (Sincalide for Injection) may be used: (1) to stimulate gallbladder contraction, as may be assessed by contrast agent cholecystography or ultrasonography, or to ob
  •   Read More
Kinevac sincalide (Pronunciation: SIN ka lide) - FDA

Description : Kinevac (Sincalide for Injection) is a cholecystopancreatic-gastrointestinal hormone peptide fo...

  • Indications
  • Kinevac (Sincalide for Injection) may be used: (1) to stimulate gallbladder contraction, as may be assessed by contrast agent cholecystography or ultrasonography, or to obtain
  •   Read More
Kinevac sincalide (Pronunciation: SIN ka lide) - Multum

Description : Kinevac (Sincalide for Injection) is a cholecystopancreatic-gastrointestinal hormone peptide fo...

  • Indications
  • Kinevac (Sincalide for Injection) may be used: (1) to stimulate gallbladder contraction, as may be assessed by contrast agent cholecystography or ultrasonography, or to obtain
  •   Read More
Kinlytic (urokinase) for Injection - FDA

Description : Kinlytic™ (urokinase for injection) is a thrombolytic agent obtained from human neona...

  • Indications
  • Kinlytic™ (urokinase injection) is indicated in adults: For the lysis of acute massive pulmonary emboli, defined as obstruction of blood flow to a lobe or multip
  •   Read More
Kinrix diphtheria, pertussis acellular, tetanus, and poli - Multum

Description : KINRIX (diptheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poli...

  • Indications
  • A single dose of KINRIX (diptheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine) is indicated for active immunization against diphth
  •   Read More
Kinrix diphtheria, pertussis acellular, tetanus, and poli - FDA

Description : KINRIX (diptheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poli...

  • Indications
  • A single dose of KINRIX (diptheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine) is indicated for active immunization against di
  •   Read More
Kinrix diphtheria, pertussis acellular, tetanus, and poli - Multum

Description : KINRIX (diptheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poli...

  • Indications
  • A single dose of KINRIX (diptheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine) is indicated for active immunization against di
  •   Read More
Kitabis Pak (tobramycin) Inhalation Solution - FDA

Description : KITABIS PAK contains tobramycin inhalation solution, USP and the PARI LC PLUS Reusable Nebu...

  • Indications
  • KITABIS PAK (co-packaging of tobramycin inhalation solution and PARI LC PLUS Reusable Nebulizer) is indicated for the management of cystic fibrosis in adults and pediatric
  •   Read More
Kitabis Pak (tobramycin) Inhalation Solution - FDA

Description : KITABIS PAK contains tobramycin inhalation solution, USP and the PARI LC PLUS Reusable Nebulize...

  • Indications
  • KITABIS PAK (co-packaging of tobramycin inhalation solution and PARI LC PLUS Reusable Nebulizer) is indicated for the management of cystic fibrosis in adults and pediatric pat
  •   Read More
Kitabis Pak (tobramycin) Inhalation Solution - FDA

Description : KITABIS PAK contains tobramycin inhalation solution, USP and the PARI LC PLUS Reusable Nebulize...

  • Indications
  • KITABIS PAK (co-packaging of tobramycin inhalation solution and PARI LC PLUS Reusable Nebulizer) is indicated for the management of cystic fibrosis in adults and pediatric pat
  •   Read More
Klaron, Mexar, Ovace, Ovace Plus, RE 10, Sebizon, Seb-Prev sulfacetamide sodium topical (Pronunciation: SUL f - FDA

Description : Each mL of Klaron® (sodium sulfacetamide lotion) Lotion, 10% contains 100 mg of sodium ...

  • Indications
  • Klaron (sodium sulfacetamide lotion) Lotion is indicated in the topical treatment of acne vulgaris.
  •   Read More
Klaron, Mexar, Ovace, Ovace Plus, RE 10, Sebizon, Seb-Prev sulfacetamide sodium topical (Pronunciation: SUL f - Multum

Description : Each mL of Klaron® (sodium sulfacetamide lotion) Lotion, 10% contains 100 mg of sodium ...

  • Indications
  • Klaron (sodium sulfacetamide lotion) Lotion is indicated in the topical treatment of acne vulgaris.
  •   Read More
Klaron, Mexar, Ovace, Ovace Plus, RE 10, Sebizon, Seb-Prev  sulfacetamide sodium topical (Pronunciation: SUL - FDA

Description : Each mL of Klaron® (sodium sulfacetamide lotion) Lotion, 10% contains 100 mg of sodium sulf...

  • Indications
  • Klaron (sodium sulfacetamide lotion) Lotion is indicated in the topical treatment of acne vulgaris.
  •   Read More
Klaron, Mexar, Ovace, Ovace Plus, RE 10, Sebizon, Seb-Prev sulfacetamide sodium topical (Pronunciation: SUL f - Multum

Description : Each mL of Klaron® (sodium sulfacetamide lotion) Lotion, 10% contains 100 mg of sodium sulf...

  • Indications
  • Klaron (sodium sulfacetamide lotion) Lotion is indicated in the topical treatment of acne vulgaris.
  •   Read More
Klonopin, Klonopin Wafer clonazepam (Pronunciation: kloe NAZ e pam) - FDA

Description : Klonopin, a benzodiazepine, is available as scored tablets with a K-shaped perforation cont...

  • Indications
  • Seizure Disorders Klonopin is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures. In patie
  •   Read More
Klonopin, Klonopin Wafer clonazepam (Pronunciation: kloe NAZ e pam) - Multum

Description : Klonopin, a benzodiazepine, is available as scored tablets with a K-shaped perforation cont...

  • Indications
  • Seizure Disorders Klonopin is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures. In patie
  •   Read More
Klonopin, Klonopin Wafer clonazepam (Pronunciation: kloe NAZ e pam) - FDA

Description : Klonopin, a benzodiazepine, is available as scored tablets with a K-shaped perforation cont...

  • Indications
  • Seizure Disorders Klonopin is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures. In patie
  •   Read More
Klonopin, Klonopin Wafer clonazepam (Pronunciation: kloe NAZ e pam) - Multum

Description : Klonopin, a benzodiazepine, is available as scored tablets with a K-shaped perforation cont...

  • Indications
  • Seizure Disorders Klonopin is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures. In patie
  •   Read More
Kombiglyze XR metformin and saxagliptin (Pronunciation: met FOR - FDA

Description : KOMBIGLYZE XR (saxagliptin and metformin HCl extended-release) tablets contain two oral ant...

  • Indications
  • KOMBIGLYZE XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both saxagliptin and
  •   Read More
Kombiglyze XR metformin and saxagliptin (Pronunciation: met FOR - Multum

Description : KOMBIGLYZE XR (saxagliptin and metformin HCl extended-release) tablets contain two oral ant...

  • Indications
  • KOMBIGLYZE XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both saxagliptin and
  •   Read More
Kombiglyze XR metformin and saxagliptin (Pronunciation: met FOR - FDA

Description : KOMBIGLYZE XR (saxagliptin and metformin HCl extended-release) tablets contain two oral antihyp...

  • Indications
  • KOMBIGLYZE XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both saxaglipti
  •   Read More
Kombiglyze XR metformin and saxagliptin (Pronunciation: met FOR - Multum

Description : KOMBIGLYZE XR (saxagliptin and metformin HCl extended-release) tablets contain two oral a...

  • Indications
  • KOMBIGLYZE XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both saxaglipti
  •   Read More
Konyne Factor IX Complex, Konyne (factor ix complex) - FDA

Description : Factor IX Complex, Konyne (factor ix complex) ® 80, heat-treated at 80°C for 72 hou...

  • Indications
  • Factor IX Complex, Konyne (factor ix complex) ® 80 is indicated for the prevention and control of bleeding caused by Factor IX deficiency due to hemophilia B. Konyne
  •   Read More
Konyne Factor IX Complex, Konyne (factor ix complex) ® 8 - FDA

Description : Factor IX Complex, Konyne (factor ix complex) ® 80, heat-treated at 80°C for 72 hou...

  • Indications
  • Factor IX Complex, Konyne (factor ix complex) ® 80 is indicated for the prevention and control of bleeding caused by Factor IX deficiency due to hemophilia B. Konyne
  •   Read More
Korlym mifepristone (Korlym) (Pronunciation: MIF e PRIS t - FDA

Description : Korlym (mifepristone) is a cortisol receptor blocker for oral administration. The chemical ...

  • Indications
  • Korlym (mifepristone) is a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome
  •   Read More
Korlym mifepristone (Korlym) (Pronunciation: MIF e PRIS t - Multum

Description : Korlym (mifepristone) is a cortisol receptor blocker for oral administration. The chemical ...

  • Indications
  • Korlym (mifepristone) is a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome
  •   Read More
Korlym mifepristone (Korlym) (Pronunciation: MIF e PRIS t - FDA

Description : Korlym (mifepristone) is a cortisol receptor blocker for oral administration. The che...

  • Indications
  • Korlym (mifepristone) is a cortisol receptor blocker indicated to controlhyperglycemia secondary to hypercortisolism in adult patients withendogenous Cushi
  •   Read More
Korlym mifepristone (Korlym) (Pronunciation: MIF e PRIS t - Multum

Description : Korlym (mifepristone) is a cortisol receptor blocker for oral administration. The che...

  • Indications
  • Korlym (mifepristone) is a cortisol receptor blocker indicated to controlhyperglycemia secondary to hypercortisolism in adult patients withendogenous Cushi
  •   Read More
Krystexxa pegloticase (Pronunciation: peg LOE ti kase) - FDA

Description : KRYSTEXXA (pegloticase) is a uric acid specific enzyme which is a PEGylated product that co...

  • Indications
  • KRYSTEXXA™ (pegloticase) is a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy.
  •   Read More
Krystexxa pegloticase (Pronunciation: peg LOE ti kase) - Multum

Description : KRYSTEXXA (pegloticase) is a uric acid specific enzyme which is a PEGylated product that co...

  • Indications
  • KRYSTEXXA™ (pegloticase) is a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy.
  •   Read More
Krystexxa pegloticase (Pronunciation: peg LOE ti kase) - FDA

Description : KRYSTEXXA (pegloticase) is a uric acid specific enzyme which is a PEGylated product that co...

  • Indications
  • KRYSTEXXA™ (pegloticase) is a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy.
  •   Read More
Krystexxa pegloticase (Pronunciation: peg LOE ti kase) - Multum

Description : KRYSTEXXA (pegloticase) is a uric acid specific enzyme which is a PEGylated product that co...

  • Indications
  • KRYSTEXXA™ (pegloticase) is a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy.
  •   Read More
Kuvan sapropterin (Pronunciation: SAP roe TER in) - FDA

Description : KUVAN (sapropterin dihydrochloride) is an orally administered Phenylalanine Hydroxylase act...

  • Indications
  • Kuvan® (sapropterin dihydrochloride) is indicated to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (
  •   Read More
Kuvan sapropterin (Pronunciation: SAP roe TER in) - Multum

Description : KUVAN (sapropterin dihydrochloride) is an orally administered Phenylalanine Hydroxylase act...

  • Indications
  • Kuvan® (sapropterin dihydrochloride) is indicated to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (
  •   Read More
Kuvan sapropterin (Pronunciation: SAP roe TER in) - FDA

Description : KUVAN (sapropterin dihydrochloride) is an orally administered Phenylalanine Hydroxylase activat...

  • Indications
  • Kuvan® (sapropterin dihydrochloride) is indicated to reduce bloodphenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (
  •   Read More
Kuvan sapropterin (Pronunciation: SAP roe TER in) - Multum

Description : KUVAN (sapropterin dihydrochloride) is an orally administered Phenylalanine Hydroxylase a...

  • Indications
  • Kuvan® (sapropterin dihydrochloride) is indicated to reduce bloodphenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (
  •   Read More
Kynamro mipomersen (Pronunciation: MYE poe mer sen) - FDA

Description : KYNAMRO (mipomersen sodium) Injection is a sterile, preservative-free, clear, colorless to ...

  • Indications
  • KYNAMRO™ is indicated as an adjunct to lipid-lowering medications and diet to reduce low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apo B), total cho
  •   Read More
Kynamro mipomersen (Pronunciation: MYE poe mer sen) - Multum

Description : KYNAMRO (mipomersen sodium) Injection is a sterile, preservative-free, clear, colorless to ...

  • Indications
  • KYNAMRO™ is indicated as an adjunct to lipid-lowering medications and diet to reduce low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apo B), total cho
  •   Read More
Kynamro mipomersen (Pronunciation: MYE poe mer sen) - Multum

Description : KYNAMRO (mipomersen sodium) Injection is a sterile, preservative-free, clear, colorless to slig...

  • Indications
  • KYNAMRO® is indicated as an adjunct to lipid-lowering medications and diet to reduce low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apo B), total cholester
  •   Read More
Kyprolis (carfilzomib) for Injection - FDA

Description : KYPROLIS (carfilzomib) for injection is an antineoplastic agent available for intravenous u...

  • Indications
  • KYPROLIS is indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies including bortezomib and an immunomodulatory agent and
  •   Read More
Kyprolis (carfilzomib) for Injection - FDA

Description : KYPROLIS (carfilzomib) for injection is an antineoplastic agent available for intravenous u...

  • Indications
  • KYPROLIS is indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies including bortezomib and an immunomodulatory agent
  •   Read More
Kytril Injection granisetron hydrochloride) Injection, for Intraven - FDA

Description : KYTRIL (granisetron hydrochloride) Injection is a serotonin-3 (5-HT3) receptor antagonist. ...

  • Indications
  • KYTRIL Injection is a serotonin-3 (5-HT3) receptor antagonist indicated for: The prevention of nausea and/or vomiting associated with initial and repeat courses of emet
  •   Read More
Kytril Injection (granisetron hydrochloride) Injection, for Intrave - FDA

Description : KYTRIL (granisetron hydrochloride) Injection is a serotonin-3 (5-HT3) receptor antagonist. ...

  • Indications
  • KYTRIL Injection is a serotonin-3 (5-HT3) receptor antagonist indicated for: The prevention of nausea and/or vomiting associated with initial and repeat courses of emet
  •   Read More
Rx Scoops
Featured Topics
Advertisements
Copyrights ©2014: Rx Scoops - Designed & Developed By - GOIGI